Fluo Labs: The Future of Allergy Relief (212)

Episode 12 • May 14, 2022 • 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 27

August 16, 2022 • 00:33:14
Episode Cover

Star Harbor: Accelerating innovation through space education, training and research (228)

Maraia Tanner is the CEO of Star Harbor based in Lone Tree, Colorado. She shares insights into the mission of the organization and how...

Listen

Episode 19

August 25, 2021 • 00:25:51
Episode Cover

Featured Startup: iVizz (019)

iVizz, is a Bay Area technology company which enables hospitals to prevent in-patient infections outbreaks.https://www.angelmd.co/en/startups/ivizz

Listen

Episode 7

July 09, 2021 • 00:19:12
Episode Cover

Andrew Malloy on Family Office Impact Investing (007)

Andrew Malloy spent a career on Wall Street and also happens to be part of a 3rd generation family office created because of his...

Listen